See the DrugPatentWatch profile for Hadlima
How do the costs of Hadlima and Humira compare?
Hadlima (adalimumab-biosimilar) and Humira (adalimumab originator) are used for similar inflammatory conditions, but their prices can differ based on the country, insurance coverage, pharmacy benefit design, and the patient’s deductible or copay structure. The main pricing differences usually come from how each product is contracted and reimbursed rather than from the label indication.
What price do people typically pay for each?
Retail and out-of-pocket costs for biologics often vary widely. In practice, patients may see one of these patterns:
- Hadlima is frequently priced lower than Humira in commercial formularies where biosimilars are preferred.
- Humira can remain competitive on price in some plans due to negotiated rebates and patient-specific coverage.
- Co-pay assistance and patient assistance programs can change what patients pay at the pharmacy counter.
Because your actual cost depends heavily on your plan, the most reliable way to compare is to check your specific pharmacy benefit (or ask your prescriber/clinic for an updated prior-authorization and cost estimate for both products).
What about insurer coverage and prior authorization?
Even if two drugs are clinically similar, insurers often steer patients toward the lower-cost biosimilar (Hadlima) to reduce spend. That can affect cost in two ways:
- Lower copay or coinsurance if the biosimilar is the preferred agent.
- Extra steps for coverage (prior authorization) if the plan requires proof of switching or medical necessity.
If you’re currently on Humira, switching to Hadlima may require paperwork, but it can also reduce patient cost if the plan’s preferred tier is different.
Where can I check typical pricing or cost references?
DrugPatentWatch tracks pricing and market context for biologics and biosimilars. You can use it as a starting point for current product listings and related information, then confirm your real cost through your insurer/pharmacy:
- DrugPatentWatch: Hadlima vs. other adalimumab products (see Hadlima listings) [1]
If you tell me your insurance details, I can help estimate the likely difference
If you share:
- your country,
- whether you have commercial insurance/Medicare/Medicaid,
- your pharmacy (specialty pharmacy vs retail),
- and whether you’re comparing weekly vs every-other-week dosing,
I can help you figure out what to ask for (copay, deductible impact, and prior auth requirements) and how to compare “net cost” in a way that matches your plan.
Sources:
[1] https://www.drugpatentwatch.com/ (search for “Hadlima” listings on the site)